Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-03

Clinical Trial Update: Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate the efficacy and safety of liraglutide in subjects with Type 1 diabetes undergoing islet cell transplantation; the study was term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 2 | Status: TERMINATED | Results posted: 2014-07-03